General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Gabonia massiliensis is a Gram-negative, non-spore-forming, anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 37.9%. Gabonia massiliensis is probably a rare gut coloniser. (Mourembou2016)



  • This organism has been recovered from human faeces (Mourembou2016). Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Mourembou2016);
    Character Response
  • 🌡
  • Temperature tolerance:
  • grows at 28℃; grows at 45℃; Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • glucose; mannose; aesculin; inulin; starch; cellubiose; lactose; maltose; raffinose; sucrose; trehalose; D-arabitol; inositol; 5-ketogluconate; α-methyl glucoside; methyl mannoside; N-Ac glucosamine;
  • Active enzymes:
  • alkaline phosphatase; acid phosphatase; N-Ac β-glucosaminidase; catalase; esterase C4; esterase lipase C8; α-galactosidase; β-galactosidase; naphthol-ASBI-P;

  • SPECIAL FEATURES (Mourembou2016);
    Character Response
  • Metabolites not produced:
  • indole;

  • RESPONSE TO ANTIBIOTICS (Mourembou2016);
    Class Active Resistant
  • Penicillins:
  • amoxicillin-clavulanic acid; imipenem;
  • amoxicillin;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • doxycycline;
  • Quinolines:
  • ciprofloxacin;
  • Aminoglycosides:
  • amikacin; gentamicin; tobramycin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • nitrofurantoin;
  • metronidazole; trimethoprim-sulfamethoxazole;
  • Vancomycins:
  • vancomycin;
  • Miscellaneous antibiotics:
  • clindamycin;

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Bacteroidetes Class:  Bacteroidia Order:  Bacteroidales Family:  Porphyromonadaceae Genus:  Gabonia Gram stain:  neg O2 Relation.:  anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  human faeces (Mourembou2016)
    DNA G+C(%):  37.9
    Opt. T:  37℃
    Lower T(℃):  28(+)
    High T(℃):  45(+)
    Urea:  neg Gelatin:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    L-Arabinose:  neg Fructose:  neg Glucose:  + Mannose:  + Ribose:  neg Xylose:  neg Cellubiose:  + Lactose:  + Maltose:  + Melezitose:  neg Sucrose:  + Trehalose:  + Aesculin:  + Inulin:  + Starch:  + D-Arabitol:  + Glycerol:  neg Inositol:  + Mannitol:  neg Sorbitol:  neg 5-Ketogluconate:  + Me-α-D-Glc:  + Me-α-D-Mann:  + NAc-α-GA:  + Salicin:  neg

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  + Urease:  neg Ac-β-glcamnd:  + α-Galactosidase:  + β-Galactosidase:  + AlkalineP:  + AcidP:  + Esterase(C4):  + EstLip(C8):  +

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Indole:  neg

    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  Res
    Augmentin:  Sens
    imipenem:  Sens
    amikacin:  Res
    gentamicin:  Res
    tobramycin:  Res
    erythromycin:  Res
    ciprofloxacin:  Res
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    doxycycline:  Sens
    vancomycin:  Res
    rifampicin:  Sens
    metronidazole:  Res
    nitrofurantoin:  Sens
    SXT:  Res
    clindamycin:  Res

    References


    SPECIFIC REFERENCES FOR GABONIA MASSILIENSIS
  • Mourembou2016 - Non-contiguous finished genome sequence and description of Gabonia massiliensis gen. nov., sp. nov.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR GABONIA MASSILIENSIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................